Pet dogs owned by lupus patients are at a higher risk of developing lupus

Lupus

Volumn 13, Issue 6, 2004, Pages 442-449

  Chiou, S H ^a   Lan, Joung Liang ^b,c   Lin, S L ^a   Chen, D Y ^b,d   Tsai, N Y ^a   Kuan, C Y ^a   Lin, T Y ^a   Lin, F J ^a,b   Lee, W M ^a   Chang, T J ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Antinuclear antibodies (ANA); Heterogeneous nuclear ribonucleoprotein G (hnRNP G); Systemic lupus erythematosus (SLE)

Indexed keywords

ANTINUCLEAR ANTIBODY; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN G; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOG; ENVIRONMENTAL FACTOR; HUMAN; NONHUMAN; OUTPATIENT; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; VETERINARY MEDICINE; ZOONOSIS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; DOG DISEASES; DOGS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREVALENCE;

EID: 3142746824     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu1039oa     Document Type: Article

References (39)

1. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
2. Hopkinson N. Epidemiology of systemic lupus erythematosus. Ann Rheum Dis 1992; 12: 1292-1294.
3. Lewis RM, Schwartz RS, Henry WB. Canine systemic lupus erythematosus. Blood 1965; 25: 143-160.
4. Scott DW, Walton DK, Manning TO, Smith CA, Lewis RM. Canine systemic lupus erythematosus. I. Systemic lupus erythematosus. J Am Anim Hosp Assoc 1983; 19: 461-479.
5. Jiménez S, Cervera R, Font J, Ingelmo M. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol 2003; 25: 3-11.
6. Lewis RM. Animal model of human disease: canine systemic lupus erythematosus. Am J Path 1972; 69: 537-540.
7. Monier JC, Ritter J, Caux C et al. Canine systemic lupus erythematosus. II: antinuclear antibodies. Lupus 1992; 1: 287-293.
8. Chabanne L, Fournel C, Monier J-C, Rigal D, Monestier M. Canine systemic lupus erythematosus. Part I. Clinical and biologic aspects. Compend Contin Educ Pract Vet 1999; 21: 135-141.
9. Beaucher WN, Garman RH, Condemi JJ. Familial lupus erythematosus: antibodies to DNA in household dogs. N Engl J Med 1977; 296: 982-984.
10. Jones DRE, Hopkinson ND, Powell RJ. Autoantibodies in pet dogs owned by patients with systemic lupus erythematosus. Lancet 1992; 339: 1378-1380.
11. Clair D, DeHoratius RJ, Wolfe J, Halliwell R. Autoantibodies in human contact of SLE dogs. Arthritis Rheum 1980; 23: 251-253.
12. Monier JC, Dardenne M, Rigal D, Costa O, Fournel C, Lapras M. Clinical and laboratory features of canine lupus syndromes. Arthritis Rheum 1980; 23: 294-301.
13. Reinertsen JL, Kaslow RA, Klippel JH et al. An epidemiologic study of households exposed to canine systemic lupus erythematosus. Arthritis Rheum 1980; 23: 564-568.
14. Kristensen S, Flagstad A, Jansen H. The absence of evidence suggesting that systemic lupus erythematosus is a zoonosis of dogs. Vet Record 1979; 105: 422-423.
15. Oxholm P, Bendixen G, Flagstad A et al. Systemic lupus erythematosus - a zoonosis? Scand J Rheumatol 1979; 8: 222-224.
16. Soulard M, Barque J-P, Della Valle V et al. A Novel 43-kDa glycoprotein is detected in the nucleus of mammalian cells by autoantibodies from dogs with autoimmune disorders. Exper Cell Res 1991; 193: 59-71.
17. Soulard M, Della Valle V, Siomi MC et al. HnRNP G: sequence and characterization of a glycosylated RNA-binding protein. Nucleic Acids Res 1993; 21: 4210-4217.
18. Chabanne L, Fournel C, Rigal D, Monier J-C. Canine systemic lupus erythematosus. Part II. Diagnosis and treatment. Compend Contin Educ Pract Vet 1999; 21: 402-421.
19. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
20. Harmon CE. Antinuclear antibodies in autoimmune disease: significance and pathogenicity. Med Clin N Am 1985; 69: 547-563.
21. Chow K-C, Pearson GD. Adenovirus infection elevates levels of cellular topoisomerase I. Proc Natl Acad Sci USA 1985; 82: 2247-2251.
22. Ben-Chetrit E, Fox RI, Tan EM. Dissociation of immune responses to the SS-A (Ro) 52 kD and 60 kD polypeptides in systemic lupus erythematosus and Sjögren's syndrome. Arthritis Rheum 1990; 33: 349-355.
23. Pettersson I, Hinterberger M, Mimori T, Gottlieb E, Steitz JA. The structure of mammalian small nuclear ribonucleoproteins: identification of multiple protein components reactive with anti-(U1) ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem 1984; 259: 5907-5914.
24. Buyon, JP, Slade SG, Chan EKL, Tan EM, Winchester R. Effective separation of the 52 kDa SSA/Ro polypeptide from the 48 kDa SSB/La polypeptide by altering conditions of polyacrylamide gel electrophoresis. J Immunol Methods 1990; 129: 207-210.
25. Tan EM. Relationship of nuclear staining patterns with precipitating antibodies in systemic lupus erythematosus. J Lab Clin Med 1967; 70: 800-812.
26. Hess EV, Farhey Y. Epidemiology, genetics, etiology, and environment relationships of systemic lupus erythematosus. Curr Opin Rheumatol 1994; 6: 474-480.
27. Fournel C, Chabanne L, Caux C et al. Canine systemic lupus erythematosus. I: a study of 75 cases. Lupus 1992; 1: 133-139.
28. Carr RI, Hoffmann AA, Harbeck RJ. Comparison of DNA binding in normal population, general hospital laboratory personnel, and personnel from laboratories studying SLE. J Rheumatol 1975; 2: 178-183.
29. DeHoratius RJ, Robin RL, Messener RP, Carr RI. Lymphocytotoxic antibodies in laboratory personnel exposed to SLE sera. Lancet 1979; 2: 1141-1142.
30. Zarmbinski MA, Messner RP, Mandel JS. Anti-dsDNA antibodies in laboratory workers handling blood from patients with systemic lupus erythematosus. J Rheumatol 1992; 19: 1380-1384.
31. Lewis RM, André-Schwartz J, Harris GS, Hirsch MS, Black PH, Schwartz RS. Canine systemic lupus erythematosus. Transmission of serologic abnormalities by cell-free filtrates. J Clin Invest 1973; 52: 1893-1907.
32. Fawaz-Estrup F. Human parvovirus infection: rheumatic manifestations, angioedema, Cl esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus. J Rheumatol 1996; 23: 1180-1185.
33. Griffiths DJ, Cooke SP, Herve C et al. Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus. Arthritis Rheum 1999; 42: 448-454.
34. Ogasawara H, Naito T, Kaneko H et al. Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus. J Rheumatol 2001; 28: 533-538.
35. Hardgrave KL, Neas BR, Scofield RH, Harley JB. Antibodies to vesicular stomatitis virus proteins in patients with systemic lupus erythematosus and in normal subjects. Arthritis Rheum 1993; 36: 962-970.
36. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997; 100: 3019-3026.
37. James JA, Neas BR, Moser KL et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001; 44: 1122-1126.
38. Newkirk MM, van Venrooij WJ, Marshall GS. Autoimmune response to U1 small nuclear ribonucleoprotein (U1 snRNP) associated with cytomegalovirus infection. Arthritis Res 2001; 3: 253-258.
39. Panush RS, Levine ML, Reichlin M. Do I need an ANA? Some thoughts about man's best friend and the transmissibility of lupus. J Rheumatol 2000; 27: 287-291.